Decision-Making Scoring System for the Repetition of Conventional Transarterial Chemoembolization in Patients With Inoperable Hepatocellular Carcinoma.

Kittipitch BannangkoonKeerati HongsakulTeeravut TubtaweePhurich JanjindamaiSurasit AkkakriseeTeerha PiratvisuthAlan Geater

Published in: Clinical and translational gastroenterology (2022)

The SMAART score can aid clinicians in selecting appropriate candidates for subsequent cTACE. A SMAART score of ≥5 after the first cTACE session identified patients with poor prognosis who may not benefit from additional cTACE sessions.

Keyphrases

poor prognosis
long non coding rna
decision making
radiofrequency ablation
palliative care
high intensity
squamous cell carcinoma
locally advanced
liver metastases